John Steytler, MBChB
Dr. Steytler oversees IPM’s pharmacovigilance (PV) and clinical development activities. He joined IPM in 2012, working in PV and medical safety and contributing medical expertise for clinical trial protocol development and assessment of product safety for all IPM products in clinical development.
Prior to IPM, Dr. Steytler worked in pharmaceutical clinical research, drug safety and medical affairs for Boehringer Ingelheim and Hoffman-La Roche (Roche) with a focus in several therapeutic areas including HIV, oncology, hepatitis B and C and autoimmune diseases. He has extensive clinical experience in HIV medicine and has been site principal investigator for HIV studies.
Dr. Steytler holds a medical degree from the University of Cape Town.